Felsher Lab In the Division of Oncology

The Felsher Lab current members

Lab Director

 
Dean Felsher, MD, PhD

Staff

 
Qiwei Yang Qiwei Yang
Transgenics manager -
The most senior member of the Felsher lab, Qiwei Yang is responsible for maintaining the transgenic animals.
Julia Arzeno Julia Arzeno
Research Assistant
- Examining the efficacy of small molecule inhibitors of the MYC oncogene.
Adriane Mosley Adriane Mosley
Laboratory Manager/ Research Assistant -
Working on translational projects and industry collaborations, in addition to laboratory management.
Jenny O'Rourke Jenny O'Rourke
Research Assistant-
Jenny works in the Felsher lab as a research assistant. She processes clinical cancer samples and preforms molecular proteomic analysis on a panel of both banked and incoming specimens using the Nanopro1000. She assesses the significance of potential biomarkers, to predict presence or absence of tumor signatures and response to therapy before interpreting the data as it applies to the field of cancer biomarkers research
  Leslie Quiroz
Administrative assistant

Instructors and Research Associates

Alice Fan, MD
Dr. Fan is an oncologist focusing on translational studies to understand the mechanism of oncogene addiction in patient tumors.  She leads several clinical trials that use nanotechnologies to profile molecular response to oncogene-directed therapies in patients. 
Yulin Li Yulin Li, MD, PhD
Instructor - Investigating the mechanism of cell death upon MYC inactivation in murine lymphoma.

Post-Doctoral Fellows

Stephanie Casey, PhD
Investigating the role of the adaptive immune system in lymphoma regression upon oncogene inactivation.
Bikul Das Bikul Das, MBBS, PhD
Studying the role of cancer stem cells in MYC-induced cancer relapse.
Meital Gabay, PhD Meital Gabay, PhD
Dr. Gabay is a examining pathways that interact with MYC in the genesis and maintenance of liver cancer.
Daniel Koch, PhD Daniel Koch, PhD
Investigating biomarkers of oncogene-addicted cancer stem cells.
Emelyn Shroff, PhD
Contributing effects of multiple oncogenes on lung and kidney tumor formation and regression.
Ling Tong, PhD
Utilizing intravital microscopy to interrogate the impact of MYC inhibition on tumor maintenance and regression.

Undergraduate Students

Rachel Do Rachel Do
Assisting in a project to characterize the role of CD4+ T-cells and the TSP-1 secreted factor in tumor regression due to MYC inactivation.
DAve Praharaj Dave Praharaj
Biology major; working on the translational kidney projects with Dr. Alice Fan. Using NIA to analyze RCC FNA samples treated ex vivo with approved targeted therapies to inhibit the VEGF and mTOR pathways.
Alia Yaghi Alia Yaghi
Identifying biomarkers in renal cell carcinoma utilizing nanotechnology.
Christine Yost
Investigating the role of microRNAs in MYC-induced lymphomagenesis.

Rotations

Santa Cristea Sandra Cristea
Graduate Student
Spring Rotation: Studying the molecular mechanisms of tumor regression after Myc inactivation in a model of ALL oncogene addiction. Using knockout and reconstituted mouse models, I plan to interrogate the intercellular signaling cascade following oncogene inactivation which causes apoptosis and senescence in tumor cells, and which mediates the presence or absence of relapse.
Former Lab Members

top

Stanford Medicine Resources:

Footer Links: